Common use of HIV Program Clause in Contracts

HIV Program. The objective of the HIV Program, as provided in the HIV Research Plan, shall be to utilize the Hookipa Technologies to Research Lymphocytic Choriomeningitis Virus- and Pichinde Virus-based vectors suitable for the Development, Manufacture, and Commercialization by Gilead, its Affiliates, or its sublicensees as HIV Licensed Products for the treatment, cure, diagnosis, or prevention of HIV.

HIV Program. The objective of the HIV Program, as provided in the HIV Research PlanPlan established under the Original Collaboration Agreement and the HIV Development Plan established under this Agreement, shall be was and is to utilize the Hookipa Technologies to Research and Develop Lymphocytic Choriomeningitis Virus- and Pichinde Virus-based vectors suitable for the further Development, Manufacture, and Commercialization by Gilead, its Affiliates, or its sublicensees as HIV Licensed Products for the treatment, cure, diagnosis, or prevention of HIV.